These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 34447360

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Antifungal susceptibility of the clinical and environmental strains of Cryptococcus gattii sensu lato in Taiwan.
    Lin KH, Lai YC, Lin YP, Ho MW, Chen YC, Chung WH.
    Mycoses; 2023 Jan; 66(1):13-24. PubMed ID: 35986599
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Molecular typing and in vitro antifungal susceptibility of Cryptococcus spp from patients in Midwest Brazil.
    Favalessa OC, de Paula DA, Dutra V, Nakazato L, Tadano T, Lazera Mdos S, Wanke B, Trilles L, Walderez Szeszs M, Silva D, Hahn RC.
    J Infect Dev Ctries; 2014 Aug 13; 8(8):1037-43. PubMed ID: 25116671
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [First description of phenotypic profile and in vitro drug susceptibility of Cryptococcus spp yeast isolated from HIV-positive and HIV-negative patients in State of Mato Grosso].
    Favalessa OC, Ribeiro LC, Tadano T, Fontes CJ, Dias FB, Coelho BP, Hahn RC.
    Rev Soc Bras Med Trop; 2009 Aug 13; 42(6):661-5. PubMed ID: 20209351
    [Abstract] [Full Text] [Related]

  • 27. Isolation of Cryptococcus gattii and Cryptococcus neoformans var. grubii from the flowers and bark of Eucalyptus trees in India.
    Gugnani HC, Mitchell TG, Litvintseva AP, Lengeler KB, Heitman J, Kumar A, Basu S, Paliwal-Joshi A.
    Med Mycol; 2005 Sep 13; 43(6):565-9. PubMed ID: 16323312
    [Abstract] [Full Text] [Related]

  • 28. Cryptococcus neoformans/gattii Species Complexes from Pre-HIV Pandemic Era Contain Unusually High Rate of Non-Wild-Type Isolates for Amphotericin B.
    Pharkjaksu S, Chongtrakool P, Chayakulkeeree M, Mitrpant C, Angkasekwinai P, Bennett JE, Kwon-Chung KJ, Ngamskulrungroj P.
    Infect Drug Resist; 2020 Sep 13; 13():673-681. PubMed ID: 32161475
    [Abstract] [Full Text] [Related]

  • 29. Seasonal variations in the prevalence of Cryptococcus neoformans var. grubii and Cryptococcus gattii in decayed wood inside trunk hollows of diverse tree species in north-western India: a retrospective study.
    Randhawa HS, Kowshik T, Chowdhary A, Prakash A, Khan ZU, Xu J.
    Med Mycol; 2011 Apr 13; 49(3):320-3. PubMed ID: 20854229
    [Abstract] [Full Text] [Related]

  • 30. In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeirão Preto, São Paulo, Brazil.
    Pedroso RS, Ferreira JC, Candido RC.
    Mem Inst Oswaldo Cruz; 2006 May 13; 101(3):239-43. PubMed ID: 16862315
    [Abstract] [Full Text] [Related]

  • 31. In vitro synergistic effect of minocycline combined with antifungals against Cryptococcus neoformans.
    Tan L, Shi H, Chen M, Wang Z, Yao Z, Sun Y.
    J Mycol Med; 2022 Mar 13; 32(1):101227. PubMed ID: 34800920
    [Abstract] [Full Text] [Related]

  • 32. [Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province].
    Lei Y, Xiao YL, He C, Zhang CY, Xie Y, Kang M.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jan 13; 46(1):82-6. PubMed ID: 25807801
    [Abstract] [Full Text] [Related]

  • 33. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
    Lee GA, Arthur I, Merritt A, Leung M.
    Med Mycol; 2019 Nov 01; 57(8):1004-1010. PubMed ID: 30649538
    [Abstract] [Full Text] [Related]

  • 34. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
    Liaw SJ, Wu HC, Hsueh PR.
    Clin Microbiol Infect; 2010 Jun 01; 16(6):696-703. PubMed ID: 19694765
    [Abstract] [Full Text] [Related]

  • 35. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK, Souza Junior AH, Costa CR, Faganello J, Vainstein MH, Chagas AL, Souza AC, Silva MR.
    Mycoses; 2010 Jan 01; 53(1):62-7. PubMed ID: 19500261
    [Abstract] [Full Text] [Related]

  • 36. Rapid identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by use of rapid biochemical tests, differential media, and DNA sequencing.
    McTaggart L, Richardson SE, Seah C, Hoang L, Fothergill A, Zhang SX.
    J Clin Microbiol; 2011 Jul 01; 49(7):2522-7. PubMed ID: 21593254
    [Abstract] [Full Text] [Related]

  • 37. Molecular epidemiology and antifungal susceptibilities of Cryptococcus species isolates from HIV and non-HIV patients in Southwest China.
    Wu SY, Kang M, Liu Y, Chen ZX, Xiao YL, He C, Ma Y.
    Eur J Clin Microbiol Infect Dis; 2021 Feb 01; 40(2):287-295. PubMed ID: 32895755
    [Abstract] [Full Text] [Related]

  • 38. Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya.
    Bii CC, Makimura K, Abe S, Taguchi H, Mugasia OM, Revathi G, Wamae NC, Kamiya S.
    Mycoses; 2007 Jan 01; 50(1):25-30. PubMed ID: 17302744
    [Abstract] [Full Text] [Related]

  • 39. Ventriculoperitoneal shunt infection by Cryptococcus neoformans sensu stricto: Case report and literature review.
    Kumar A, Udayakumaran S, Sachu A, Shashindran N, Baby P, Thaha A, Kurien A, Chowdhary A.
    Rev Iberoam Micol; 2022 Jan 01; 39(1):16-20. PubMed ID: 35248468
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of antifungal combination against Cryptococcus spp.
    Reichert-Lima F, Busso-Lopes AF, Lyra L, Peron IH, Taguchi H, Mikami Y, Kamei K, Moretti ML, Schreiber AZ.
    Mycoses; 2016 Sep 01; 59(9):585-93. PubMed ID: 27135278
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.